Form 4: Dynavax Technologies COO David Novack Sells Shares

Dynavax Technologies' President and COO, David Novack, sold 32,764 shares of common stock on March 7, 2025, at a weighted average price of $14.39.

Summary

• David Novack, President & COO of Dynavax Technologies Corp, reported a transaction involving the sale of Dynavax common stock.
• On March 7, 2025, Novack sold 32,764 shares of common stock.
• The sale was executed at a weighted average price of $14.39 per share, with individual trades ranging from $14.22 to $14.61.
• Following the transaction, Novack directly owns 22,098 shares of Dynavax common stock.
• The sale was conducted under a pre-arranged 10b5-1 trading plan adopted on December 6, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. The sale was conducted under a pre-arranged 10b5-1 trading plan.

Industry Context

Insider sales are a common occurrence and are often scrutinized by investors to gauge management's confidence in the company's future prospects. However, sales under a 10b5-1 plan are pre-arranged and may not necessarily reflect the insider's current view of the company.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates